Search

Douglas Anthony Bakan

from Del Mar, CA
Age ~63
Get Report
Also known as:
Douglas A Bakan, Doug A Bakan, Douglas A Zepeda
Related to:
Rosaura G Zepeda, 96Charles N Bakan, 86Eric D Bakan, 30Michael G Bakan, 28Janice E Bakan, 86Monica O Zepeda, 61Elaine V Bakan, 60Gregory A Bakan, 61Clotilde M Zepeda, 87Jessica L Bakan, 29Henry O Zepeda
Connected to:
Ayse Bakan, 36Martin J Bakan, 69Sarah C Bakan, 37Brett A Bakanec, 42Jacob Bakane, 31Jerry M Bakanec, 76Dawn C Bakanowsky, 52Greta M Bakanowski, 50Nancy A Bakanowicz, 59Paul F Bakanowski, 77

Douglas Bakan Phones & Addresses

  • Del Mar, CA
  • 11652 Chesterwood Pl, San Diego, CA 92130 (858) 350-9576 (858) 523-9254 (858) 342-2268
  • 4247 Calle Mejillones, San Diego, CA 92130 (858) 350-9576
  • Fort Worth, TX
  • Ann Arbor, MI
  • Scottsdale, AZ
  • Poway, CA
  • Oceanside, CA
  • 11652 Chesterwood Pl, San Diego, CA 92130 (858) 350-9576

Work

Position: Production Occupations

Education

Degree: Graduate or professional degree

Business Records

Name / Title
Company / Classification
Phones & Addresses
Douglas Bakan
Executive
Goleta National Bank
Mortgage Bankers and Correspondents
5355 Mira Sorrento Pl, San Diego, CA 92121
(858) 597-7577
Douglas Bakan
President, Vice-President
Alerion Biomedical Inc
Pharmaceutical Preparations Research & Development
6370 Nancy Rdg Dr, San Diego, CA 92121
(858) 558-2191

Publications

Us Patents

High Throughput Screening Methods Using Magnetic Resonance Imaging Agents

View page
US Patent:
20020197648, Dec 26, 2002
Filed:
May 2, 2002
Appl. No.:
10/139145
Inventors:
Robin Silva - Burlingame CA, US
Thomas Meade - Willmette IL, US
Douglas Bakan - San Diego CA, US
International Classification:
C12Q001/68
G01N033/53
A61K049/00
C07K014/00
C07F005/00
US Classification:
435/007100, 435/006000, 424/009340, 424/009350, 424/009360, 530/350000, 534/015000
Abstract:
The invention relates to a wide variety of different methods and compositions that find use in high throughput screening applications utilizing magnetic resonance imaging (MRI) contrast agents.

Novel Functional Agents For Magnetic Resonance Imaging

View page
US Patent:
20030021750, Jan 30, 2003
Filed:
Apr 4, 2002
Appl. No.:
10/116706
Inventors:
Douglas Bakan - San Diego CA, US
Thomas Meade - Altadena CA, US
International Classification:
A61K049/00
A61K038/00
C07K007/00
US Classification:
424/009360, 534/015000, 534/016000, 530/324000
Abstract:
The present invention is directed to non-macrocyclic functional MRI contrast agents that can be used to detect the presence of physiological target substances.

High Throughput Screening Methods Using Magnetic Resonance Imaging Agents

View page
US Patent:
20030135108, Jul 17, 2003
Filed:
Nov 7, 2002
Appl. No.:
10/291807
Inventors:
Robin Silva - Burlingame CA, US
Thomas Meade - Willmette IL, US
Douglas Bakan - San Diego CA, US
International Classification:
A61B005/055
US Classification:
600/420000
Abstract:
The invention relates to a wide variety of different methods and compositions that find use in high throughput screening applications utilizing magnetic resonance imaging (MRI) contrast agents.

Novel Macrocyclic Activatible Magnetic Resonance Imaging Contrast Agents

View page
US Patent:
20030198597, Oct 23, 2003
Filed:
Apr 22, 2002
Appl. No.:
10/131616
Inventors:
Thomas Meade - Altadena CA, US
Douglas Bakan - San Diego CA, US
International Classification:
A61K049/00
C07F005/00
C07H017/02
C07K014/47
US Classification:
424/009340, 424/009350, 530/400000, 534/015000, 536/017400
Abstract:
The invention relates to novel magnetic resonance imaging contrast agents and methods of detecting physiological signals or substances.

Functional Mri Agents For Cancer Imaging

View page
US Patent:
20040146463, Jul 29, 2004
Filed:
Oct 24, 2003
Appl. No.:
10/693252
Inventors:
Thomas Meade - Wilmette IL, US
Matthew Allen - Madison WI, US
Douglas Bakan - San Diego CA, US
International Classification:
A61K049/00
C12N009/64
US Classification:
424/009323, 435/226000, 530/409000
Abstract:
The invention relates to novel magnetic resonance imaging contrast agents for imaging cancer.

Characterization Of An Antibiotic Imregnated Delivery Systems As An Intracanal Medicament In Endodontic Therapy

View page
US Patent:
20120021384, Jan 26, 2012
Filed:
Jun 10, 2011
Appl. No.:
13/157395
Inventors:
Philip P. Stashenko - Medfield MA, US
Douglas A. Bakan - San Diego CA, US
Derek Kelaita - San Diego CA, US
Robert Bruce Rutherford - Seattle WA, US
International Classification:
A61C 5/02
US Classification:
433224
Abstract:
Endodontic fibers comprising a biocompatible polymer vehicle permeable to medicaments, or combinations of medicaments, wherein the biocompatible polymer vehicle comprises one or more biocompatible and/or biodegradable polymers are described. Such fibers can be used, for example, in a method for the local delivery and sustained release of medicaments to periodontal or intracanal treatment sites. Endodontic fibers described include periodontal fibers and intracanal fibers.

Hepatocyte-Selective Oil-In-Water Emulsion

View page
US Patent:
61032166, Aug 15, 2000
Filed:
Nov 15, 1996
Appl. No.:
8/737429
Inventors:
Raymond E. Counsell - Ann Arbor MI
Marc A. Longino - Ann Arbor MI
Jamey P. Weichert - Ann Arbor MI
Douglas A. Bakan - San Diego CA
Assignee:
The Board of Regents acting for and on behalf of the University of
Michigan - Ann Arbor MI
International Classification:
A61K 5112
A61K 4904
A61K 9107
B01F 300
US Classification:
424 185
Abstract:
A heat and shelf-stable oil-in-water emulsion useful as a tissue or cell-selective delivery vehicle. Radioactive or stable, synthetic or semi-synthetic polyhalogenated triglycerides, such as 2-oleoylglycerol-1,3-bis[7-(3-amino-2,4,6-triiodophenyl)heptanoate] or 2-oleoylglycerol-1,3-bis[. omega. -(3,5-bis-trifluoromethyl)-heptanoate] or phenyl acetate, can be incorporated into the lipophilic core of a lipoprotein-like emulsion particle. The lipophilic core is surrounded by a phospholipid membrane comprising cholesterol and apolipoproteins. For hepatocyte-selective delivery, the emulsion is chylomicron remnant-like by being in a size range of 50 to 200 nm as measured by number weighting analysis with a narrow size distribution (

Hepatocyte-Selective Oil-In-Water Emulsion

View page
US Patent:
61269468, Oct 3, 2000
Filed:
Jul 23, 1997
Appl. No.:
8/899411
Inventors:
Raymond E. Counsell - Ann Arbor MI
Marc A. Longino - Ann Arbor MI
Jamey P. Weichert - Ann Arbor MI
Douglas A. Bakan - Ann Arbor MI
Assignee:
University of Michigan, The Board of Regents - Ann Arbor MI
International Classification:
A61K 9107
B01J 1300
US Classification:
424401
Abstract:
A heat and shelf-stable oil-in-water emulsion useful as a tissue or cell-selective delivery vehicle. Radioactive or stable, synthetic or semi-synthetic polyhalogenated triglycerides, such as 2-oleoylglycerol-1,3-bis[7-(3-amino-2,4,6-triiodophenyl)heptanoate] or 2-oleoylglycerol-1,3-bis[. omega. -(3,5-bis-trifluoromethyl)hepatanoate] or phenyl acetate, can be incorporated into the lipophilic core of a lipoprotein-like emulsion particle. The lipophilic core is surrounded by a phospholipid membrane comprising cholesterol and apolipoproteins. For hepatocyte-selective delivery, the emulsion is chylomicron remnant-like by being in a size range of 50 to 200 nm as measured by number weighting analysis with a narrow size distribution (
Control profile
Douglas Anthony Bakan from Del Mar, CA, age ~63 Get Report